Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hyoscine hydrobromide adverse reaction |
Causative agent |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
allergi mot skopolaminhydrobromid |
Causative agent |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Scopolamine hydrobromide 0.25% solution |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Hyoscine hydrobromide 400 microgram oral tablet |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Scopolamine hydrobromide |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
skopolaminhydrobromid 0,25 %, ögondroppar |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
skopolaminhydrobromid 0,125 %, ögondroppar |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
skopolaminhydrobromid 0,5 %, ögondroppar |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Hyoscine hydrobromide [eye] |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Ophthalmic hyoscine hydrobromide |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
atropinsulfat + hyoscyaminsulfat + skopolaminhydrobromid |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
skopolaminhydrobromid 1 mg/72 timmar, depåplåster |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
papaveretum 15,4 mg + skopolamin 400 mikrogram, injektionsvätska, lösning, ampull 1 ml |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
papaveretum + skopolaminhydrobromid |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Hyoscine hydrobromide 150 microgram oral tablet |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Hyoscine hydrobromide [central nervous system use] |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Hyoscine hydrobromide [anesthesia] |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
hyoscinhydrobromid |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
skopolaminhydrobromid för parenteralt bruk |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
skopolaminhydrobromid för transdermalt bruk |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
allergi mot skopolaminhydrobromid |
Causative agent |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Scopolamine hydrobromide trihydrate (substance) |
Is a |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Hyoscine hydrobromide 150 microgram oral tablet |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Hyoscine hydrobromide 150 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Hyoscine hydrobromide 400 microgram oral tablet |
Has active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Hyoscine hydrobromide 400 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Scopolamine hydrobromide trihydrate (substance) |
Is modification of (attribute) |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
|
Hyoscine hydrobromide 150 microgram oral tablet |
Has precise active ingredient |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Hyoscine hydrobromide 400 microgram oral tablet |
Has precise active ingredient |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
2 |
skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has precise active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Has precise active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
papaveretum 15,4 mg/ml + skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
papaveretum 15,4 mg/ml + skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has precise active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution |
Has precise active ingredient |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Hyoscine (as hyoscine hydrobromide) 5 mg/mL eye solution |
Has precise active ingredient |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Hyoscine hydrobromide adverse reaction |
Causative agent |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Scopolamine hydrobromide (substance) |
Inferred relationship |
Some |
1 |